Time to market access in Italia: durata del processo di P&R per i farmaci per le malattie rare

OBJECTIVE: This paper aims to investigate the duration of the pricing & reimbursement (P&R) procedures submitted in Italy by pharmaceutical marketing authorization holders (MAH) for drugs indicated for rare diseases. METHODS: All the data used in this analysis were publicly available on diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcellusi, Andrea, Raimondo, Paola, Galeone, Carlotta, Canonico, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628501/
https://www.ncbi.nlm.nih.gov/pubmed/37942299
http://dx.doi.org/10.33393/grhta.2023.2610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628501/
https://www.ncbi.nlm.nih.gov/pubmed/37942299
http://dx.doi.org/10.33393/grhta.2023.2610

Ejemplares similares